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Symposia
Cannabis and Psychosis: From 
Neuroscience to Clinical Intervention 
(NISAD Symposium)
A Baker
Centre for Mental Health Studies, The University of Newcastle, New South Wales, 
Australia
Overview
Cannabis use has been associated with the onset, 
course and relapse of psychosis. Population studies 
and data from samples of young people at high risk 
for psychosis have indicated that cannabis use may 
be related to the onset of psychosis. Cannabis use has 
also been found to have a deleterious impact on psy-
chotic symptom severity and has emerged as the strong 
predictor of psychotic relapse. To date, there has been 
little collaboration between neuroscience and clinical 
research groups examining the link between cannabis 
use and psychosis, despite the potential for these fi elds 
to inform the other. This symposium seeks to begin to 
redress this gap.
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Heterozygous neuregulin 1 mice are 
more sensitive to the behavioural 
effects of D9-tetrahydrocannabinol
JC Arnold1,2, AA Boucher1,2,3, L Duffy2,4, 
PR Schofi eld2,4,5,6, J Micheau3, TF Karl2,4
1Department of Pharmacology, University of Sydney, Sydney, New South Wales, 
Australia; 2Neuroscience Institute of Schizophrenia and Allied Disorders (NISAD), 
New South Wales, Australia; 3Laboratoire de Neurosciences Cognitives, Université 
Bordeaux I, Talence, France; 4Neuroscience Research Program, Garvan Institute of 
Medical Research, New South Wales, Australia; 5Prince of Wales Medical Research 
Institute, Sydney, New South Wales, Australia; and 6University of 
New South Wales, Sydney, New South Wales, Australia
Rationale: Environmental stressors such as cannabis 
use may precipitate schizophrenia especially if the 
individual has a genetic vulnerability to the disease. 
 Human and animal research indicates that neuregulin 
1 (Nrg1) is a susceptibility gene for schizophrenia.
Aim: The aim of this study was to investigate whether 
dysfunction in the Nrg1 gene modulates the behav-
ioural effects of 9-tetrahydrocannabinol (THC), the 
major psychotropic component of cannabis.
Methods: Heterozygous Nrg1 transmembrane- domain 
knockout mice (Nrg1 HET) were treated with acute 
THC (0, 5 or 10 mg/kg i.p.) 30 min before being 
tested in the open fi eld (OF), hole board, light-dark 
(LD), elevated plus maze (EPM), social interaction 
(SI) and prepulse inhibition (PPI) tests.
Results: Nrg1 HET mice showed differences in base-
line behaviour in regard to locomotor activity, explo-
ration and anxiety. More importantly, they were more 
sensitive to the locomotor suppressant actions of THC 
compared with wild-type-like (WT) mice. In addition, 
Nrg1 HET mice expressed a greater THC-induced en-
hancement in per cent PPI than WT mice. The effects 
of THC on anxiety-related behaviour were task depen-
dent, with Nrg1 HET mice being more susceptible than 
WT mice to the anxiogenic effects of THC in LD, but 
not in the EPM, SI and OF tests.
Conclusions: Nrg1 HET mice were more sensitive 
to the acute effects of THC in an array of different 
behaviours including those that model symptoms of 
schizophrenia. It appears that variation in the schizo-
phrenia-related neuregulin 1 gene alters the sensitivity 
to the behavioural effects of cannabinoids.
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Cannabis and cognitive function: 
relevant to psychosis
N Solowij
Illawarra Institute for Mental Health, School of Psychology, University of 
Wollongong, Wollongong, New South Wales, Australia
Cognitive impairments are among the most debilitat-
ing symptoms of mental illness and most highly pre-
dictive of functional outcomes. Cannabis intoxication 
impairs cognitive processes and there is increasing ev-
idence for longer lasting impairment with long-term or 
heavy cannabis use. Cognitive dysfunction associated 
with chronic cannabis use is similar in many respects 
to the cognitive endophenotypes that have recently 
been proposed as vulnerability markers of schizophre-
nia. The prevalence of cannabis use among people 
with psychotic disorders, the potential for cannabis 
to trigger psychotic symptoms and episodes, and the 
neurobiological interactions between the endogenous 
cannabinoid system and the pathology associated 
with psychosis indicate a need to further investigate 
the nature and mechanisms of cognitive impairments 
associated with cannabis use. The endogenous can-
nabinoid system plays a signifi cant role in attention, 
learning and memory in particular, and in mediating 
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inhibitory and excitatory regulatory mechanisms in 
the brain. There is evidence that the endocannabinoid 
system is altered in schizophrenia and accumulating 
evidence of disturbances in the system associated with 
exposure to cannabis or cannabinoids. This presenta-
tion will  summarize what is known about the long-
term cognitive effects of cannabis, describing some 
of the most recent research and its relevance to 
 psychotic disorders.
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fMRI in schizophrenia and cannabis 
users
M Cohen1,2,4, V Carr1,2,4, PB Ward3,4, T Ehlkes4, 
P Johnston2,4, R Thienel4, U Schall1,2,4
1Hunter New England Mental Health; 2Centre for Mental Health Studies, The 
University of Newcastle; 3The Hunter Neuroscience & Brain and Mental Health 
Research Program, Hunter Medical Research Institute (HMRI); and 
4Neuroscience Institute of Schizophrenia and Allied Disorders (NISAD), 
New South Wales, Australia
Background: The cerebral activation changes associ-
ated with the overlapping cognitive features of canna-
bis use and schizophrenia have not been systematically 
studied. The Tower of London Task (TOL) was used to 
assess functional brain activation in these two groups 
and in comorbid fi rst-episode schizophrenia and can-
nabis users.
Methods: Event-related functional magnetic reso-
nance imaging measured cerebral activation during the 
TOL task in 12 patients with fi rst-episode schizophre-
nia, 17 recently abstinent long-term cannabis users, 7 
recently abstinent cannabis using patients with schizo-
phrenia and 17 healthy subjects. A two-stage random-
effects analysis was used to model the BOLD response 
to assess cortical activation as a function of increasing 
task diffi culty and to assess for the main effect of each 
diagnosis.
Results: We found prefrontal activation defi cits in pa-
tients with schizophrenia that overlapped with canna-
bis users. A statistical trend in the comorbid subjects 
for reduced BOLD activation in the left superior pari-
etal lobule and prefrontal cortices was observed. The 
diagnosis of schizophrenia largely accounted for the 
prefrontal defi cit, while a history of heavy cannabis 
use associated with increased BOLD activation in the 
visual cortex.
Conclusions: There were common defi cits in activation 
of the dorsolateral prefrontal cortex to the most diffi -
cult tasks. Ancillary brain regions were recruited, pos-
sibly to subserve the demands of complex TOL tasks. 
The combination of cannabis use and  schizophrenia 
may exert a synergistic effect on altering frontal lobe 
recruitment during high-demand cognitive tasks.
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Visual scanpath comparisons 
between those people with and 
without comorbid cannabis abuse: 
the implications for eye movement 
research in schizophrenia
C Loughland1,2, K McCabe1,2, S Quinn2, M Hunter1,2, 
T Lewin1,3
1Neuroscience Institute of Schizophrenia and Allied Disorders (NISAD), New South 
Wales, Australia; 2The University of Newcastle, Callaghan, New South Wales, 
Australia; and 3Hunter New England Health, Newcastle, Australia
Background: Cannabis use is associated with substan-
tial social cognition impairment, as are illnesses such 
as schizophrenia. Schizophrenia is also strongly asso-
ciated with comorbid cannabis use. Studies examining 
face processing disturbances show that people with 
schizophrenia display impaired visual scanpath (VS) 
strategies when viewing face stimuli. No studies to 
date have examined the impact of cannabis use on VS 
performance, and whether VS disturbances in schizo-
phrenia are further impaired by comorbid cannabis 
use. This study examines whether VS disturbances to 
face stimuli are observed in cannabis users.
Methods: The sample consisted of 20 subjects with 
regular cannabis use and 20 healthy controls. Subjects 
were screened for psychosis (SCID-N/P). IQ was as-
sessed using the NART and neuropsychological func-
tioning using the RBANS. Personality was assessed 
using the SPQ and the IPDE. VSs were recorded using 
a ViewPoint (6.0) eye tracker. Recognition accuracy 
was recorded concurrently.
Results: Preliminary analysis indicates that the two 
groups did not differ from each other on age, gender, 
secondary school completion, IQ or neuropsychologi-
cal functioning. However, cannabis users had signifi -
cantly higher scores than controls on the SPQ items of 
odd beliefs/magical thinking and odd speech, but did 
not differ from each other on VS or facial expression 
recognition accuracy.
Conclusions: These fi ndings suggest that the social 
cognition disturbances observed in cannabis users 
may be associated with social cue and personality dis-
turbances rather than disturbances in face perception 
and processing. The implications for VS research in 
schizophrenia will be discussed.
